<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiac allograft dysfunction is a major cause of morbidity and mortality in the early post-transplantation period </plain></SENT>
<SENT sid="1" pm="."><plain>This is a critical condition that requires prompt diagnosis and management </plain></SENT>
<SENT sid="2" pm="."><plain>We present the case of a 57-year-old man with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> who underwent cardiac transplantation and developed a rare case of coronary artery <z:mp ids='MP_0005048'>thrombosis</z:mp> in the setting of <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> and <z:mp ids='MP_0005048'>thrombosis</z:mp> syndrome (HITTS) within the first 2 postoperative weeks </plain></SENT>
<SENT sid="3" pm="."><plain>Transmural <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (MI) was initially noted on cardiac magnetic resonance (CMR) imaging as regional left ventricular wall motion abnormalities and transmural hyperenhancement after <z:chebi fb="0" ids="33375">gadolinium</z:chebi> administration, prompting further evaluation of the coronary circulation with angiography </plain></SENT>
</text></document>